These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

304 related articles for article (PubMed ID: 8064230)

  • 41. Expression of vascular permeability factor (VPF/VEGF) messenger RNA by plasma cells: possible involvement in the development of edema in chronic inflammation.
    Ito A; Hirota S; Mizuno H; Kawasaki Y; Takemura T; Nishiura T; Kanakura Y; Katayama Y; Nomura S; Kitamura Y
    Pathol Int; 1995 Oct; 45(10):715-20. PubMed ID: 8563931
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.
    Senger DR; Ledbetter SR; Claffey KP; Papadopoulos-Sergiou A; Peruzzi CA; Detmar M
    Am J Pathol; 1996 Jul; 149(1):293-305. PubMed ID: 8686754
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Up-regulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastomas.
    Wizigmann-Voos S; Breier G; Risau W; Plate KH
    Cancer Res; 1995 Mar; 55(6):1358-64. PubMed ID: 7533661
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The shortest isoform of human vascular endothelial growth factor/vascular permeability factor (VEGF/VPF121) produced by Saccharomyces cerevisiae promotes both angiogenesis and vascular permeability.
    Kondo S; Matsumoto T; Yokoyama Y; Ohmori I; Suzuki H
    Biochim Biophys Acta; 1995 Feb; 1243(2):195-202. PubMed ID: 7533000
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overexpression of vascular endothelial growth factor (VEGF) and its cellular receptor KDR (VEGFR-2) in the bone marrow of patients with acute myeloid leukemia.
    Padró T; Bieker R; Ruiz S; Steins M; Retzlaff S; Bürger H; Büchner T; Kessler T; Herrera F; Kienast J; Müller-Tidow C; Serve H; Berdel WE; Mesters RM
    Leukemia; 2002 Jul; 16(7):1302-10. PubMed ID: 12094254
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Vascular permeability factor/vascular endothelial growth factor: an important mediator of angiogenesis in malignancy and inflammation.
    Dvorak HF; Detmar M; Claffey KP; Nagy JA; van de Water L; Senger DR
    Int Arch Allergy Immunol; 1995; 107(1-3):233-5. PubMed ID: 7542074
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Production of VEGF and expression of the VEGF receptors Flt-1 and KDR in primary cultures of epithelial and stromal cells derived from breast tumours.
    Speirs V; Atkin SL
    Br J Cancer; 1999 May; 80(5-6):898-903. PubMed ID: 10360672
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Expression of vascular endothelial growth factor and its receptors in the human corpus luteum during the menstrual cycle and in early pregnancy.
    Sugino N; Kashida S; Takiguchi S; Karube A; Kato H
    J Clin Endocrinol Metab; 2000 Oct; 85(10):3919-24. PubMed ID: 11061557
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Correlation of angiogenesis with expression of vascular endothelial growth factor and its receptors in lung carcinoma].
    Zhang G; Zhao M; Xu M; Yang Y; Wang M; Yang C
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):89-93. PubMed ID: 11953105
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Hypoxia regulates vascular endothelial growth factor receptor KDR/Flk gene expression through adenosine A2 receptors in retinal capillary endothelial cells.
    Takagi H; King GL; Ferrara N; Aiello LP
    Invest Ophthalmol Vis Sci; 1996 Jun; 37(7):1311-21. PubMed ID: 8641834
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vascular endothelial growth factor (VEGF) enhances the expression of receptors and activates mitogen-activated protein (MAP) kinase of dog retinal capillary endothelial cells.
    Murata M; Kador PF; Sato S
    J Ocul Pharmacol Ther; 2000 Aug; 16(4):383-91. PubMed ID: 10977134
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prognostic value of vascular endothelial growth factor and its receptors Flt-1 and Flk-1 in astrocytic tumours.
    Yao Y; Kubota T; Sato K; Kitai R; Takeuchi H; Arishima H
    Acta Neurochir (Wien); 2001; 143(2):159-66. PubMed ID: 11459088
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Vascular endothelial growth factor, its receptor KDR/Flk-1, and pituitary tumor transforming gene in pituitary tumors.
    McCabe CJ; Boelaert K; Tannahill LA; Heaney AP; Stratford AL; Khaira JS; Hussain S; Sheppard MC; Franklyn JA; Gittoes NJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4238-44. PubMed ID: 12213878
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors.
    Marti HH; Risau W
    Proc Natl Acad Sci U S A; 1998 Dec; 95(26):15809-14. PubMed ID: 9861052
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of vascular permeability factor/vascular endothelial growth factor by melanoma cells increases tumor growth, angiogenesis, and experimental metastasis.
    Claffey KP; Brown LF; del Aguila LF; Tognazzi K; Yeo KT; Manseau EJ; Dvorak HF
    Cancer Res; 1996 Jan; 56(1):172-81. PubMed ID: 8548760
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expression of vascular endothelial growth factors and their receptors during osteoblast differentiation.
    Deckers MM; Karperien M; van der Bent C; Yamashita T; Papapoulos SE; Löwik CW
    Endocrinology; 2000 May; 141(5):1667-74. PubMed ID: 10803575
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vascular endothelial growth factor up-regulates its receptor fms-like tyrosine kinase 1 (FLT-1) and a soluble variant of FLT-1 in human vascular endothelial cells.
    Barleon B; Siemeister G; Martiny-Baron G; Weindel K; Herzog C; Marmé D
    Cancer Res; 1997 Dec; 57(23):5421-5. PubMed ID: 9393770
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expression of vascular permeability factor (VPF/VEGF) is altered in many glomerular diseases.
    Shulman K; Rosen S; Tognazzi K; Manseau EJ; Brown LF
    J Am Soc Nephrol; 1996 May; 7(5):661-6. PubMed ID: 8738799
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Serum and platelet-derived growth factor-induced expression of vascular permeability factor mRNA by human vascular smooth muscle cells in vitro.
    Williams B; Quinn-Baker A; Gallacher B
    Clin Sci (Lond); 1995 Feb; 88(2):141-7. PubMed ID: 7720337
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Advances in the study of the role of vascular endothelial growth factor and its receptor in tumor angiogenesis and its relation with anti-angiogenesis effect].
    Bian X; Shi J
    Zhonghua Bing Li Xue Za Zhi; 1997 Aug; 26(4):248-50. PubMed ID: 10072871
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.